Short answer · Medically reviewed summary · Last updated: 2026-04-07
Polycystic Ovary Syndrome (PCOS) is most formally recognized as Stein-Leventhal syndrome in historical medical literature, though today it is almost exclusively referred to as PCOS or Polycystic Ovary Syndrome. Historical and Alternative Nomenclature Historically, the condition was widely known as Stein-Leventhal syndrome, named after the physicians Irving F. Stein and Michael L.
1 people with Polycystic Ovary Syndrome have shared their first-person experience on this question at DiseaseMaps.
Polycystic Ovary Syndrome (PCOS) is most formally recognized as Stein-Leventhal syndrome in historical medical literature, though today it is almost exclusively referred to as PCOS or Polycystic Ovary Syndrome.
Historically, the condition was widely known as Stein-Leventhal syndrome, named after the physicians Irving F. Stein and Michael L. Leventhal who first described the association between polycystic ovaries, amenorrhea, and hirsutism in 1935. While you may still see this term in older medical textbooks or legacy patient records, it is now considered an outdated eponym. You might also encounter terms like "hyperandrogenic anovulation" in research papers, which describes the underlying hormonal mechanism of the syndrome rather than using a diagnostic label.
In global clinical practice, the official classification follows the International Classification of Diseases (ICD-10 code E28.2). Under the ICD-11 system, it is categorized under "Polycystic ovarian syndrome." Because Polycystic Ovary Syndrome is a complex endocrine disorder that affects multiple body systems, including the reproductive and nervous systems, it is often referred to by various descriptive phrases in different countries. In some regions, patients may hear it described as "ovarian hyperandrogenism," though this is more of a clinical feature than a formal diagnosis.
The variety of names for Polycystic Ovary Syndrome stems from the evolution of our medical understanding. Originally, the condition was defined by the physical appearance of the ovaries on ultrasound. As research progressed, clinicians realized that Polycystic Ovary Syndrome is actually a systemic metabolic and endocrine disorder. Consequently, the medical community moved away from the ovary-centric "Stein-Leventhal" label toward a more comprehensive, syndrome-based name that reflects its impact on insulin resistance, mental health, and reproductive function. Today, Polycystic Ovary Syndrome remains the preferred nomenclature globally, ensuring consistency for patients seeking care across different specialists.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.